Johnson & Johnson vs. Sionna Therapeutics, Inc. Common Stock
Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| JNJ | SION | |
|---|---|---|
| Market Cap | $624.74 billion | $203.46 million |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-97,383,000 |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| JNJ | SION | |
|---|---|---|
| Price / Book | — | 0.77 |
JNJ and SION split the valuation factors evenly.
Profitability
| JNJ | SION | |
|---|---|---|
| Return on Equity | — | -36.64% |
JNJ and SION split the profitability factors evenly.
Dividend
| JNJ | SION | |
|---|---|---|
| Dividend Yield | 2.05% | — |
JNJ and SION split the dividend factors evenly.
Risk & Sentiment
| JNJ | SION | |
|---|---|---|
| Short Interest | 0.67% | 1.39% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, SION overview, SION financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.